← Open Payments lookup

BABAK GHADISHAH: Open Payments

NPI 1346272408 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,117 in 41 payments from 15 companies in 2025. Trend: 2023 $1,217 · 2024 $1,310 · 2025 $1,117

Food & beverage: $1,117
CompanyPaymentsAmount
Edwards Lifesciences Corporation2$203
Otsuka America Pharmaceutical, Inc.4$194
GlaxoSmithKline, LLC.5$116
Boehringer Ingelheim Pharmaceuticals, Inc.5$99
Novo Nordisk Inc5$90
ABBVIE INC.4$82
Astellas Pharma US Inc4$81
PFIZER INC.3$72
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$39
Medtronic, Inc.1$33

Products named: REXULTI, SAPIEN 3 Ultra RESILIA, JARDIANCE, UBRELVY, Veozah, SHINGRIX, NURTEC ODT, Rybelsus.

Industry payments across NV — which companies pay providers there.